Food Allergy Peanut Clinical Trial
Official title:
Intra-lymphatic Immunotherapy for the Management of Peanut Allergy
Use of three intralymphatic injections of peanut allergen one month apart to induce tolerance to peanut in peanut allergic people.
Eligible subject undergo a baseline blinded oral peanut challenge. Then the peanut ILIT as described above. Pretreatment with antihistamines, leukotriene modifier and albuterol before each treatment. Following the three ILIT peanut injections a repeat blinded oral peanut challenge is performed. Blood is drawn at each of the 5 study visits for a variety of tests trying to elucidate the mechanism(s) of the induction of tolerance to peanut. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06260956 -
Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
|
N/A | |
| Enrolling by invitation |
NCT04604431 -
Intervention to Reduce Early (Peanut) Allergy in Children
|
N/A | |
| Recruiting |
NCT06192914 -
EPAP, Interviewstudy
|
||
| Recruiting |
NCT05695261 -
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
|
Phase 2 | |
| Completed |
NCT05038904 -
Preventing Anaphylaxis With Acalabrutinib
|
Phase 2 | |
| Recruiting |
NCT05407012 -
TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel Food Processing and Skin Care Adaptations
|
N/A |